Free Trial

Avantor (AVTR) Competitors

Avantor logo
$15.54 -0.08 (-0.48%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$15.52 -0.02 (-0.13%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVTR vs. A, RVTY, TMO, MTD, and ILMN

Should you buy Avantor stock or one of its competitors? Avantor's main competitors and comparable companies include Agilent Technologies (A), Revvity (RVTY), Thermo Fisher Scientific (TMO), Mettler-Toledo International (MTD), and Illumina (ILMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Avantor compare to Agilent Technologies?

Avantor (NYSE:AVTR) and Agilent Technologies (NYSE:A) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

Agilent Technologies has a net margin of 19.53% compared to Avantor's net margin of 5.08%. Agilent Technologies' return on equity of 24.45% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor5.08% 9.79% 4.74%
Agilent Technologies 19.53%24.45%13.09%

Avantor presently has a consensus target price of $14.77, indicating a potential downside of 5.01%. Agilent Technologies has a consensus target price of $181.45, indicating a potential upside of 4.29%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Agilent Technologies is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
1 Sell rating(s)
13 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.06
Agilent Technologies
0 Sell rating(s)
4 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
2.82

95.1% of Avantor shares are held by institutional investors. 0.3% of Avantor shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Avantor has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market.

Agilent Technologies has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.55B1.61-$530.20M$0.5031.09
Agilent Technologies$6.95B7.06$1.30B$5.0834.25

In the previous week, Agilent Technologies had 6 more articles in the media than Avantor. MarketBeat recorded 11 mentions for Agilent Technologies and 5 mentions for Avantor. Agilent Technologies' average media sentiment score of 0.46 beat Avantor's score of 0.42 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilent Technologies
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Agilent Technologies beats Avantor on 14 of the 16 factors compared between the two stocks.

How does Avantor compare to Revvity?

Revvity (NYSE:RVTY) and Avantor (NYSE:AVTR) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Revvity has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revvity$2.86B6.04$241.20M$2.2668.41
Avantor$6.55B1.61-$530.20M$0.5031.09

Revvity presently has a consensus price target of $133.86, indicating a potential downside of 13.42%. Avantor has a consensus price target of $14.77, indicating a potential downside of 5.01%. Given Avantor's higher probable upside, analysts clearly believe Avantor is more favorable than Revvity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revvity
0 Sell rating(s)
13 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.32
Avantor
1 Sell rating(s)
13 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.06

In the previous week, Revvity had 3 more articles in the media than Avantor. MarketBeat recorded 8 mentions for Revvity and 5 mentions for Avantor. Revvity's average media sentiment score of 1.01 beat Avantor's score of 0.42 indicating that Revvity is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revvity
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Revvity has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market. Comparatively, Avantor has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market.

Revvity has a net margin of 8.61% compared to Avantor's net margin of 5.08%. Avantor's return on equity of 9.79% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Revvity8.61% 8.64% 5.24%
Avantor 5.08%9.79%4.74%

86.7% of Revvity shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 0.9% of Revvity shares are owned by insiders. Comparatively, 0.3% of Avantor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Revvity beats Avantor on 12 of the 16 factors compared between the two stocks.

How does Avantor compare to Thermo Fisher Scientific?

Thermo Fisher Scientific (NYSE:TMO) and Avantor (NYSE:AVTR) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Thermo Fisher Scientific has a net margin of 14.94% compared to Avantor's net margin of 5.08%. Thermo Fisher Scientific's return on equity of 17.33% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Thermo Fisher Scientific14.94% 17.33% 8.18%
Avantor 5.08%9.79%4.74%

Thermo Fisher Scientific has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market. Comparatively, Avantor has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market.

Thermo Fisher Scientific currently has a consensus target price of $683.64, indicating a potential downside of 2.33%. Avantor has a consensus target price of $14.77, indicating a potential downside of 5.01%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, equities analysts plainly believe Thermo Fisher Scientific is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Thermo Fisher Scientific
0 Sell rating(s)
4 Hold rating(s)
23 Buy rating(s)
2 Strong Buy rating(s)
2.93
Avantor
1 Sell rating(s)
13 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.06

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 0.3% of Avantor shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Thermo Fisher Scientific has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Thermo Fisher Scientific$44.56B5.82$6.70B$18.9636.92
Avantor$6.55B1.61-$530.20M$0.5031.09

In the previous week, Thermo Fisher Scientific had 30 more articles in the media than Avantor. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 5 mentions for Avantor. Thermo Fisher Scientific's average media sentiment score of 1.14 beat Avantor's score of 0.42 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Thermo Fisher Scientific
26 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Thermo Fisher Scientific beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Mettler-Toledo International?

Avantor (NYSE:AVTR) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

Avantor presently has a consensus target price of $14.77, indicating a potential downside of 5.01%. Mettler-Toledo International has a consensus target price of $1,595.77, indicating a potential downside of 8.20%. Given Avantor's higher probable upside, research analysts plainly believe Avantor is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
1 Sell rating(s)
13 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.06
Mettler-Toledo International
1 Sell rating(s)
8 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.33

Mettler-Toledo International has a net margin of 22.25% compared to Avantor's net margin of 5.08%. Mettler-Toledo International's return on equity of 15,012.71% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor5.08% 9.79% 4.74%
Mettler-Toledo International 22.25%15,012.71%25.41%

Mettler-Toledo International has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.55B1.61-$530.20M$0.5031.09
Mettler-Toledo International$4.03B8.59$869.19M$46.1537.67

In the previous week, Mettler-Toledo International had 22 more articles in the media than Avantor. MarketBeat recorded 27 mentions for Mettler-Toledo International and 5 mentions for Avantor. Mettler-Toledo International's average media sentiment score of 0.69 beat Avantor's score of 0.42 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Mettler-Toledo International
11 Very Positive mention(s)
2 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Avantor has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.16, meaning that its share price is 16% more volatile than the broader market.

95.1% of Avantor shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.3% of Avantor shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Mettler-Toledo International beats Avantor on 13 of the 16 factors compared between the two stocks.

How does Avantor compare to Illumina?

Avantor (NYSE:AVTR) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Avantor has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market. Comparatively, Illumina has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market.

Illumina has lower revenue, but higher earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.55B1.61-$530.20M$0.5031.09
Illumina$4.34B7.21$850M$5.8135.63

Illumina has a net margin of 19.72% compared to Avantor's net margin of 5.08%. Illumina's return on equity of 28.38% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor5.08% 9.79% 4.74%
Illumina 19.72%28.38%12.11%

95.1% of Avantor shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 0.3% of Avantor shares are owned by insiders. Comparatively, 2.9% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Avantor currently has a consensus price target of $14.77, indicating a potential downside of 5.01%. Illumina has a consensus price target of $244.24, indicating a potential upside of 17.98%. Given Illumina's stronger consensus rating and higher possible upside, analysts clearly believe Illumina is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
1 Sell rating(s)
13 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.06
Illumina
3 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.37

In the previous week, Illumina had 24 more articles in the media than Avantor. MarketBeat recorded 29 mentions for Illumina and 5 mentions for Avantor. Illumina's average media sentiment score of 0.55 beat Avantor's score of 0.42 indicating that Illumina is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Illumina
12 Very Positive mention(s)
5 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Positive

Summary

Illumina beats Avantor on 14 of the 16 factors compared between the two stocks.

Get Avantor News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVTR vs. The Competition

MetricAvantorLife Sciences Tools & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$10.58B$11.03B$7.87B$23.49B
Dividend YieldN/A1.45%2.46%3.78%
P/E Ratio31.0952.4834.5629.82
Price / Sales1.617.218.623.42
Price / Cash10.3226.6921.9315.51
Price / Book1.814.584.353.72
Net Income-$530.20M$57.48B$3.52B$1.08B
7 Day Performance0.36%-0.51%-1.52%0.58%
1 Month Performance-3.32%-0.85%-3.54%-0.31%
1 Year Performance36.66%21.49%1.45%7.30%

Avantor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTR
Avantor
2.4734 of 5 stars
$15.55
-0.5%
$14.77
-5.0%
N/A$10.58B$6.55B31.0913,500
A
Agilent Technologies
3.922 of 5 stars
$180.09
+3.0%
$181.45
+0.8%
N/A$49.95B$6.95B29.2418,100
RVTY
Revvity
2.7183 of 5 stars
$160.96
+3.8%
$133.86
-16.8%
N/A$17.79B$2.86B28.7311,000
TMO
Thermo Fisher Scientific
3.6693 of 5 stars
$721.96
+3.9%
$683.64
-5.3%
N/A$261.64B$44.56B38.08125,000
MTD
Mettler-Toledo International
2.7038 of 5 stars
$1,762.04
+2.3%
$1,595.77
-9.4%
N/A$34.53B$4.03B38.4018,100

Related Companies and Tools


This page (NYSE:AVTR) was last updated on 11/15/2026 by MarketBeat.com Staff.
From Our Partners